AU6476599A - Anti-inflammatory 4-phenyl-5-pyrimidinyl-imidazoles - Google Patents
Anti-inflammatory 4-phenyl-5-pyrimidinyl-imidazolesInfo
- Publication number
- AU6476599A AU6476599A AU64765/99A AU6476599A AU6476599A AU 6476599 A AU6476599 A AU 6476599A AU 64765/99 A AU64765/99 A AU 64765/99A AU 6476599 A AU6476599 A AU 6476599A AU 6476599 A AU6476599 A AU 6476599A
- Authority
- AU
- Australia
- Prior art keywords
- imidazoles
- pyrimidinyl
- inflammatory
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Transplantation (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9824063 | 1998-11-03 | ||
GBGB9824063.3A GB9824063D0 (en) | 1998-11-03 | 1998-11-03 | Organic compounds |
GBGB9903440.7A GB9903440D0 (en) | 1999-02-15 | 1999-02-15 | Organic compounds |
GB9903440 | 1999-02-15 | ||
PCT/EP1999/008358 WO2000026209A1 (en) | 1998-11-03 | 1999-11-02 | Anti-inflammatory 4-phenyl-5-pyrimidinyl-imidazoles |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6476599A true AU6476599A (en) | 2000-05-22 |
Family
ID=26314604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU64765/99A Abandoned AU6476599A (en) | 1998-11-03 | 1999-11-02 | Anti-inflammatory 4-phenyl-5-pyrimidinyl-imidazoles |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6476599A (en) |
WO (1) | WO2000026209A1 (en) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998007425A1 (en) | 1996-08-21 | 1998-02-26 | Smithkline Beecham Corporation | Imidazole compounds, compositions and use |
US7301021B2 (en) | 1997-07-02 | 2007-11-27 | Smithkline Beecham Corporation | Substituted imidazole compounds |
BR9910621A (en) | 1998-05-22 | 2001-01-30 | Smithkline Beecham Corp | New 2-alkyl imidazole substituted compounds |
DE69933680T2 (en) | 1998-08-29 | 2007-08-23 | Astrazeneca Ab | PYRIMIDINE COMPOUNDS |
ATE336484T1 (en) | 1998-08-29 | 2006-09-15 | Astrazeneca Ab | PYRIMIDINE COMPOUNDS |
GB9828511D0 (en) | 1998-12-24 | 1999-02-17 | Zeneca Ltd | Chemical compounds |
GB9905075D0 (en) | 1999-03-06 | 1999-04-28 | Zeneca Ltd | Chemical compounds |
GB9907658D0 (en) | 1999-04-06 | 1999-05-26 | Zeneca Ltd | Chemical compounds |
US6291457B1 (en) * | 1999-07-01 | 2001-09-18 | Merck & Co., Inc. | Compounds having cytokine inhibitory activity |
GB9919778D0 (en) | 1999-08-21 | 1999-10-27 | Zeneca Ltd | Chemical compounds |
HUP0203403A3 (en) * | 1999-11-22 | 2004-01-28 | Smithkline Beecham Plc | New imidazole derivatives, pharmaceutical compositions containing them and their use |
GB0004888D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
GB0004886D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
GB0004890D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
GB0004887D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
GB0007371D0 (en) | 2000-03-28 | 2000-05-17 | Astrazeneca Uk Ltd | Chemical compounds |
IL152450A0 (en) | 2000-05-12 | 2003-05-29 | Genzyme Corp | COMPOUNDS HAVING TNF-alpha SIGNAL MODULATING ACTIVITY |
GB0016877D0 (en) | 2000-07-11 | 2000-08-30 | Astrazeneca Ab | Chemical compounds |
US7087224B2 (en) * | 2000-10-31 | 2006-08-08 | Amgen Inc. | Method of treating anemia by administering IL-1ra |
CA2437248A1 (en) * | 2001-02-02 | 2002-08-15 | Takeda Chemical Industries, Ltd. | Jnk inhibitor |
MY130778A (en) | 2001-02-09 | 2007-07-31 | Vertex Pharma | Heterocyclic inhibitiors of erk2 and uses thereof |
GB0103926D0 (en) | 2001-02-17 | 2001-04-04 | Astrazeneca Ab | Chemical compounds |
US6727364B2 (en) | 2001-04-30 | 2004-04-27 | The Procter & Gamble Company | Triazole compounds useful in treating diseases associated with unwanted cytokine activity |
US6787555B2 (en) | 2001-04-30 | 2004-09-07 | The Procter & Gamble Company | Triazole compounds useful in treating diseases associated with unwanted cytokine activity |
US6790846B2 (en) | 2001-05-24 | 2004-09-14 | The Procter & Gamble Company | Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity |
GB0113041D0 (en) | 2001-05-30 | 2001-07-18 | Astrazeneca Ab | Chemical compounds |
GB0205693D0 (en) | 2002-03-09 | 2002-04-24 | Astrazeneca Ab | Chemical compounds |
GB0205690D0 (en) | 2002-03-09 | 2002-04-24 | Astrazeneca Ab | Chemical compounds |
GB0205688D0 (en) | 2002-03-09 | 2002-04-24 | Astrazeneca Ab | Chemical compounds |
WO2003076434A1 (en) | 2002-03-09 | 2003-09-18 | Astrazeneca Ab | 4- imidazolyl substuited pyrimidine derivatives with cdk inhibitiory activity |
US20040122008A1 (en) * | 2002-09-05 | 2004-06-24 | Protter Andrew A. | Treatment of pain by inhibition of p38 MAP kinase |
EP1534282B1 (en) | 2002-07-09 | 2006-12-27 | Boehringer Ingelheim Pharma GmbH & Co.KG | Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
WO2004019873A2 (en) * | 2002-08-29 | 2004-03-11 | Scios Inc. | Methods of promoting osteogenesis |
JP2006502183A (en) | 2002-09-20 | 2006-01-19 | アルコン,インコーポレイテッド | Use of cytokine synthesis inhibitors for the treatment of dry eye disorders |
GB0311274D0 (en) | 2003-05-16 | 2003-06-18 | Astrazeneca Ab | Chemical compounds |
GB0311276D0 (en) | 2003-05-16 | 2003-06-18 | Astrazeneca Ab | Chemical compounds |
TW200528101A (en) | 2004-02-03 | 2005-09-01 | Astrazeneca Ab | Chemical compounds |
US20060035893A1 (en) | 2004-08-07 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
PE20060777A1 (en) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | INDOLINONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES |
CA2623374A1 (en) | 2005-09-30 | 2007-04-05 | Astrazeneca Ab | Imidazo [1,2-a] pyridine having anti-cell-proliferation activity |
EP1992344A1 (en) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation |
ES2573278T3 (en) | 2013-06-20 | 2016-06-07 | Tampereen Yliopisto | Medium containing p38 MAPK inhibitor and method for osteogenic differentiation |
CN110041302B (en) * | 2019-03-01 | 2021-11-30 | 南方医科大学 | 2-amino-4-substituted pyridine derivative and synthesis method and application thereof |
WO2020192302A1 (en) * | 2019-03-27 | 2020-10-01 | 广州必贝特医药技术有限公司 | Pyrimidine-containing tri-substituted imidazole compound and application thereof |
CN111356687B (en) * | 2019-03-27 | 2021-03-30 | 广州必贝特医药技术有限公司 | Pyrimidine-containing tri-substituted imidazole compound and application thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5658903A (en) * | 1995-06-07 | 1997-08-19 | Smithkline Beecham Corporation | Imidazole compounds, compositions and use |
US5977103A (en) * | 1996-01-11 | 1999-11-02 | Smithkline Beecham Corporation | Substituted imidazole compounds |
JP3418624B2 (en) * | 1996-06-10 | 2003-06-23 | メルク エンド カンパニー インコーポレーテッド | Substituted imidazoles having cytokine inhibitory activity |
WO1998007425A1 (en) * | 1996-08-21 | 1998-02-26 | Smithkline Beecham Corporation | Imidazole compounds, compositions and use |
ZA9711092B (en) * | 1996-12-11 | 1999-07-22 | Smithkline Beecham Corp | Novel compounds. |
-
1999
- 1999-11-02 WO PCT/EP1999/008358 patent/WO2000026209A1/en active Application Filing
- 1999-11-02 AU AU64765/99A patent/AU6476599A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000026209A1 (en) | 2000-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6476599A (en) | Anti-inflammatory 4-phenyl-5-pyrimidinyl-imidazoles | |
AU3485999A (en) | Neo-tryptophan | |
AU9392998A (en) | Pack-a-pillow | |
AU3437799A (en) | City-car | |
AU3522399A (en) | Carvedilol-galenics | |
AUPP328398A0 (en) | Remove-a-line | |
AU5407599A (en) | Sphingolipid-desaturase | |
AU3253699A (en) | Myxochelines | |
AU8363398A (en) | Capotasto | |
AU2609599A (en) | Sensor-coupling | |
AU3204999A (en) | Futureball | |
AU2069199A (en) | Codelets | |
AU1055399A (en) | Rollerboard | |
AU3347599A (en) | Aeromobile | |
AU9347498A (en) | Imidazotriazolopyrimidines | |
AU5223199A (en) | Bathtub-bathseat | |
AU3819799A (en) | Methoximinomethyloxathiazines | |
AU2840799A (en) | 1-phosphanorbornadienes | |
AU4768799A (en) | Bookcover | |
AU1779099A (en) | Heterocyclyl-derivatives | |
AU9218098A (en) | Exocyclic-phosphoethanolamines | |
AUPP305498A0 (en) | Infahaler | |
AUPP263198A0 (en) | Gyrocopter | |
AUPP184898A0 (en) | Lifepad | |
AUPP143698A0 (en) | Ezi-tarp |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |